BORTEZOMIB EQUITY


Powder for solution for injection
scheduling status
S4
registration number
56/26/0040
What BORTEZOMIB EQUITY contains
Each vial contains 3,5 mg bortezomib (as a mannitol boronic ester).
other ingredients
Mannitol (E421) Nitrogen.
Therapeutic classification
L01XG01.
© 2026 SAHPRA. ALL RIGHTS RESERVED